Active Ingredient(s): Ferumoxytol
FDA Approved: * June 30, 2009
Pharm Company: * AMAG PHARMS INC
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Feraheme Overview

FeO.Fe2O3 Molar mass 231.533 g/mol Appearance solid black powder Density 5 g/cm3 Melting point 1,597°C (2,907°F; 1,870K) Boiling point 2,623[1]°C (4,753°F; 2,896K) Refractive index (nD) 2.42[2] Hazards NFPA 704 (firediamond) 0 0 1OX Except where otherwise noted, data are given for materials in their...

Read more Feraheme Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Iron(II,III)_oxide

Recent Feraheme Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: eq 510mg iron/17ml (eq 30mg iron/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Feraheme: (1 result)

Sorted by National Drug Code
  • 59338-775 Feraheme 510 mg/17ml Intravenous Injection by Amag Pharmaceuticals, Inc.

Other drugs which contain Ferumoxytol or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA